(A) Schematic illustration of the hippocampus indicating the pictured area in (B).
(B) PBS- or TTX-containing Elvax was implanted on the hippocampus of DG-A::TeTxLC-tau-lacZ mice at P15 and their hippocampi were stained with the anti-β-gal antibody (green) at P23 to visualize TeTxLC-expressing axons (8 days total of TTX-Elvax application). Nuclei were stained with DAPI (red). In PBS-treated mice, few TeTxLC-expressing axons remained in CA3 (arrows). In contrast, in TTX-treated mice, many TeTxLC-expressing axons were maintained in CA3 (arrowheads). Scale bar is 50 μm.
(C) Quantification of the intensity of β-gal staining in the hilar region of PBS- or TTX-treated DG-A::TeTxLC-tau-lacZ mice. Data are shown as percentage of PBS control. Bars are mean ± SEM. Data are from 6 mice. Differs from the PBS-treated mice at *p < 0.01 by Student’s t-test.
See also Figure S3.